NHS National Framework for Transition products (Axitinib and Eltrombopag)
- NHS England
Procurement identifier (OCID): ocds-h6vhtk-050bb9
Description
Project title: NHS National Framework for Transition products (Axitinib and Eltrombopag) commencing 1st October 2025
Offer reference number: CM/TNS/25/5722
Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum of 48 months.
Potential periods of call-offs under the framework agreement:
CM/TNS/25/5722/01 Axitinib and Eltrombopag
Lot 1 CESW: 01/10/2025 to 31/01/2027 (16 months)
Lot 2 LSNE: 01/10/2025 to 31/05/2026 (8 months)
Lot 3 NWLN: 01/10/2025 to 31/01/2027 (16 months)
Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England
Please note that the contract had erroneously been advertised as an open framework at the tender stage and should have been advertised as a standalone framework.
Notices
UK7: Contract details notice
- Notice identifier
- 2025/S 000-054095
- Published
- 4 September 2025, 5:47pm
UK6: Contract award notice
- Notice identifier
- 2025/S 000-044175
- Published
- 30 July 2025, 11:23am
UK4: Tender notice
- Notice identifier
- 2025/S 000-029971
- Published
- 4 June 2025, 3:34pm
UK2: Preliminary market engagement notice
- Notice identifier
- 2025/S 000-018549
- Published
- 1 May 2025, 4:18pm